BTSG Gains More Than 54% YTD: Should You Buy, Hold or Sell?

BrightSpring Health Services has surged 54% YTD on specialty pharmacy, infusion and EBITDA growth, but premium valuation and policy headwinds remain.

Zacks Investment Research • Sep 11, 2026

BTSG's Specialty Pharmacy Sales Up 30%: Will the Growth Continue?

BrightSpring Health Services' Specialty and Infusion sales rose 30%, backed by LDD growth, new launches and expansion into rare therapies.

Zacks Investment Research • Sep 10, 2026

BrightSpring Health Services: 44% Ebitda Growth Is Hard To Ignore

BrightSpring Health Services is rated buy, driven by rapid profitability growth, expanding Provider Services, and reduced financial leverage. In Q2, revenue grew 23% and adjusted EBITDA surged 44%, with management raising 2026 guidance for both revenue and EBITDA. BTSG's premium 34.38x FY1 P/E is justified by strong EBITDA growth and a forward PEG of 0.73x, with multiples declining to 22.19x by FY3.

Seeking Alpha • Sep 10, 2026

Can BTSG Outgrow the $20B Acute Infusion Market on Volume Growth?

BrightSpring Health Services is gaining acute infusion share with 20%+ volume growth, targeting 12-15 new states in a $20 billion market.

Zacks Investment Research • Sep 4, 2026

NVIDIA & 2 Profitable Stocks to Buy in September for Big Upside

NVDA's 63.7% net profit margin and 93.3% expected earnings growth put it among three profitable stocks positioned for market volatility.

Zacks Investment Research • Sep 4, 2026

New Strong Buy Stocks for August 26th

BTSG, OPHC, HRTG, UMC and MTG have been added to the Zacks Rank #1 (Strong Buy) List on August 26th, 2026.

Zacks Investment Research • Aug 26, 2026

Best Momentum Stocks to Buy for August 26th

BTSG, ANIK and OPHC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 26th, 2026.

Zacks Investment Research • Aug 26, 2026

Zacks Industry Outlook CareDx, BrightSpring and PACS

CareDx, BrightSpring and PACS have been highlighted in this Industry Outlook article.

Zacks Investment Research • Aug 25, 2026

3 Non-Tech Thriving Nasdaq Stocks Enabling Its Northward Move in 2026

IBKR, ROKU and BTSG are thriving on Nasdaq, backed by product expansion, streaming growth and care migration.

Zacks Investment Research • Aug 24, 2026

3 Medical Service Stocks Resilient Amid Persistent Workforce Shortage

CareDx, BrightSpring and PACS Group are positioned for growth as digital health expands and workforce shortages reshape medical services.

Zacks Investment Research • Aug 24, 2026